Cortisol Hijack: The Adrenal Transition in Perimenopause

The biological mechanism of the menopausal transition involves a shift in the primary site of steroidogenesis from the ovaries to the adrenal glands and peripheral tissues. The adrenals are capable of producing androstenedione and DHEA, which are converted into oestrone and oestradiol. However, in the modern world, chronic activation of the HPA (Hypothalamic-Pituitary-Adrenal) axis creates a 'cortisol hijack'. Since cortisol and progesterone share the same precursor, pregnenolone, the body will always prioritize the production of the survival hormone (cortisol) over the sex hormones.

This is often colloquially known as the 'pregnenolone steal'. Conventional medicine misses this connection, treating the symptoms of low oestrogen while ignoring the fact that the adrenal glands are too exhausted to provide the necessary hormonal buffer. Research indicates that women with higher cortisol-to-DHEA ratios experience more significant cognitive decline and bone density loss during menopause. Environmental factors like blue light exposure at night, caffeine overconsumption, and psychological stress exacerbate this adrenal burden.

Practical takeaways for managing this transition include implementing a 'circadian reset' to lower evening cortisol, utilizing adaptogens like Ashwagandha to modulate the stress response, and focusing on magnesium threonate to support the nervous system. Without addressing the adrenal 'theft' of hormonal precursors, even the highest doses of HRT may fail to provide relief, as the body remains in a state of perceived biological threat.